HERV-W-related RNA detected in plasma from individuals with recent-onset schizophrenia or schizoaffective disorder SIR -In a previous study, we identified retroviral RNA of, presumably, endogenous origin in the cerebrospinal fluids (CSFs) of 10/35 individuals with recent-onset schizophrenia or schizoaffective disorder. 1 The majority (7/10) of these patients harbored sequences related to the HERV-W family of human endogenous retroviruses. In the present study, we tested plasma from first hospitalized patients with DSM IV schizophrenia, schizoaffective psychosis, or schizophreniform disor- der (n¼54, median age: 27.3 years, range: 30 years) and healthy controls (n¼46, median age: 31.1 years, range: 29 years) for the presence of HERV-W-related RNA. Of the cases, 33 were included in a previous study on CSF. 1 Informed consent was obtained from all study participants and approval was obtained from the ethics committee, University of Heidelberg. Patients had received neuroleptics (high-potency butyrophenones in 40 patients) for a maximum of 14 days prior to study intake. We adopted a protocol more suitable for larger numbers of samples that would allow the isolation of RNA from retroviral particles completely free of contaminating genomic DNA (see supplementary information).
Bovine leukemia virus (BLV) RNA was extracted from FLK-cell supernatant and from samples where the supernatant was diluted 10-1000 times in human plasma. BLV-encoded RNA was detected by RT-PCR using specific primers in these samples. HERV-Wrelated gag sequences were subsequently detected in the plasma of 9/54 individuals with recent-onset schizophrenia. Related sequences were detected in 2/ 46 healthy controls (w 2 ¼3.85, P¼0.05, df¼1). All PCR products were cloned and sequence verified. The possibility that the amplified gag-encoded sequences merely indicate the differential presence of cellrelated RNA in some samples is less likely, since GAPDH-encoded mRNA could not be detected in any of the samples. Additionally, retroviral sequences could not be amplified from the DNase-treated RNA not subjected to reverse transcription (not shown), indicating that the amplicons do not represent contaminating genomic DNA.
Moreover, five of the nine patients who tested positive in plasma were previously found to harbor retroviral RNA in their CSF, whereas only 3/24 CSF negative patients tested positive in plasma in the present study (w 2 ¼6.6, Po0.01, df¼1). While age, gender and medication did not differ significantly between HERV-W-positive and -negative patients, the former showed a tendency to have more pronounced acuity of psychotic symptoms with higher scores on the Positive and Negative Syndrome Scale on admission 2 (median/range: 127/39 vs 108/ 112; P¼0.06) and less favorable values on the StraussCarpenter Prognostic Scale 3 (median/range: 51/34 vs 60/54; P¼0.06).
At present it is not clear what role, if any, these sequences play in the etiopathogenesis of schizophrenia. In general, a large number of studies have previously shown associations between schizophrenia and antibodies to different viruses, 4 including retroviruses. 5, 6 Johnston et al 7 reported that the stimulation of human monocytes induced the expression of HERV-W RNA in parallel to that of TNF-a. Taken together, these findings indicate that the expression of HERV-W RNA present in particles detectable in both CSF and plasma from patients with recent-onset schizophrenia may be secondary to a primary infectious event 8 eliciting an inflammatory response in the host. Lavillette et al 9 reported that the envelope protein encoded by an HERV-W locus uses the ASCT1 and 2 proteins as its cellular receptors. These are proteins mediating transport of certain amino acids with ASCT2 showing specificity for glutamine. In the light of this finding one may hypothesize on interference of the HERV-W envelope protein with glutamatergic transmission by impairing neuronal glutamine uptake, as has been shown for related animal retroviruses using the same receptor ortholog. 10 In conclusion, the presence of particles containing HERV-W RNA in the plasma of a subgroup of patients with recent-onset schizophrenia supports our previous finding in the CSF, and warrants further studies in different clinical states and with different psychiatric diagnoses to determine the validity and specificity of the current finding. 
